These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 13476152)

  • 1. Preliminary clinical experience with E-39, a new drug for advanced cancer.
    FIGUR L; SILVERSTONE SM
    J Mt Sinai Hosp N Y; 1957; 24(5):627-32. PubMed ID: 13476152
    [No Abstract]   [Full Text] [Related]  

  • 2. New, expanded, and modified use of approved antineoplastic agents in ovarian cancer.
    Markman M
    Oncologist; 2007 Feb; 12(2):186-90. PubMed ID: 17296814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New approaches in systemic treatment of advanced colorectal cancer: the molecular targets era.
    Capdevila J; Mendez G; Macarulla T; Ramos FJ; Casado E; Tabernero J
    Expert Rev Anticancer Ther; 2007 Jul; 7(7):1027-41. PubMed ID: 17627462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDA approves new drug for specific type of advanced breast cancer.
    Mayo Clin Womens Healthsource; 2007 Oct; 11(10):3. PubMed ID: 18418907
    [No Abstract]   [Full Text] [Related]  

  • 5. New targeted treatments in lung cancer--overview of clinical trials.
    Korfee S; Gauler T; Hepp R; Pöttgen C; Eberhardt W
    Lung Cancer; 2004 Aug; 45 Suppl 2():S199-208. PubMed ID: 15552800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced ovarian cancer: a clinical update on first-line treatment, recurrent disease, and new agents.
    Ozols RF
    J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 2():S60-73. PubMed ID: 19780247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New cytotoxic agents: a review of the literature.
    Hotta K; Ueoka H
    Crit Rev Oncol Hematol; 2005 Jul; 55(1):45-65. PubMed ID: 15927843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging drugs for ovarian cancer.
    Kelland LR
    Expert Opin Emerg Drugs; 2005 May; 10(2):413-24. PubMed ID: 15934876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel therapeutics for melanoma.
    Seetharamu N; Ott PA; Pavlick AC
    Expert Rev Anticancer Ther; 2009 Jun; 9(6):839-49. PubMed ID: 19496721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in chemotherapy against advanced or metastatic colorectal cancer.
    Omura K
    Digestion; 2008; 77 Suppl 1():13-22. PubMed ID: 18204257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The development of novel agents for the treatment of colorectal cancer: a critical review of current practice and some suggestions for the future.
    Marshall JL; Gehan EA
    Clin Adv Hematol Oncol; 2007 Mar; 5(3):167-72. PubMed ID: 17519876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Construction and evaluation of new anti-cancer drug prescription support system to promote proper use of anticancer drugs].
    Shudai M; Fujii K; Kuroda J; Niwa S; Mizuno H; Wanibe M; Maeda T; Kimura K; Komatsu H; Hasegawa S
    Gan To Kagaku Ryoho; 2008 Oct; 35(10):1717-20. PubMed ID: 18931575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New drug therapies for advanced renal cell carcinoma.
    Gore ME; Harrison ML; Montes A
    Expert Rev Anticancer Ther; 2007 Jan; 7(1):57-71. PubMed ID: 17187520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The convergent development of molecular-targeted drugs for cancer treatment and prevention.
    Lippman SM; Heymach JV
    Clin Cancer Res; 2007 Jul; 13(14):4035-41. PubMed ID: 17634526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thalidomide--new prospective therapy in oncology].
    Pałgan K; Pałgan I
    Wiad Lek; 2003; 56(9-10):455-9. PubMed ID: 15049211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigational agents for epithelial ovarian cancer.
    Muggia F; Kosloff R
    Expert Rev Anticancer Ther; 2005 Oct; 5(5):855-68. PubMed ID: 16221055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progresses in the medical treatment of advanced colorectal cancer.
    Sultan-Amar V; Fabre-Guillevin E; Piedbois P
    Rocz Akad Med Bialymst; 2005; 50():97-100. PubMed ID: 16358946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the development of models in mice of advanced visceral metastatic disease for anti-cancer drug testing.
    Man S; Munoz R; Kerbel RS
    Cancer Metastasis Rev; 2007 Dec; 26(3-4):737-47. PubMed ID: 17846863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer clinical trials: development and implementation.
    Vail DM
    Vet Clin North Am Small Anim Pract; 2007 Nov; 37(6):1033-57; v. PubMed ID: 17950881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histology-based treatment: a new scenario in the management of advanced nonsmall cell lung cancer.
    Gridelli C
    Curr Opin Oncol; 2009 Mar; 21(2):97-8. PubMed ID: 19532008
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.